Post-traumatic headache, unspecified, not intractable
ICD-10 Code: G44.309 · Body Part: Head/Brain (TBI)
QME Evaluation Process
Headache diary review, frequency and severity assessment, imaging review, medication response assessment. Brain impairment per Chapter 13.
Typical Impairment Rating
0-14% WPI based on headache frequency and treatment response
AMA Guides Edition
5th Edition
Common Treatments
Related Conditions
Body Part Guide
Head/Brain (TBI) Evaluation Guide
Impairment rating methods, common conditions, and QME evaluation protocols
QME Specialties for Post-traumatic headache, unspecified, not intractable
Find a QME Specialist
Browse QME-certified physicians who evaluate post-traumatic headache, unspecified, not intractable and related head/brain (tbi) conditions in California.
Browse Neurology Physicians →Frequently Asked Questions
What is Post-traumatic headache, unspecified, not intractable (G44.309)?
Post-traumatic headache, unspecified, not intractable is an ICD-10 diagnosis code (G44.309) classified under Neurological conditions. It affects the Head/Brain (TBI) and is commonly encountered in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.
How is G44.309 rated for impairment?
The typical whole person impairment (WPI) range for Post-traumatic headache, unspecified, not intractable is 0-14% WPI based on headache frequency and treatment response. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.
What is the QME evaluation process for G44.309?
Headache diary review, frequency and severity assessment, imaging review, medication response assessment. Brain impairment per Chapter 13.
What treatments are common for Post-traumatic headache, unspecified, not intractable?
Common treatments for Post-traumatic headache, unspecified, not intractable include Prophylactic medication, Nerve blocks, Physical therapy for cervicogenic component, Behavioral therapy. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.